Search

Your search keyword '"G. Di Lucca"' showing total 44 results

Search Constraints

Start Over You searched for: Author "G. Di Lucca" Remove constraint Author: "G. Di Lucca"
44 results on '"G. Di Lucca"'

Search Results

1. Impact on Survival of Timing and Duration of Adjuvant Chemotherapy in Radically Resected Gastric Cancer

2. Profiling cancer-related needs and the role of physical, practical and psychological difficulties: A latent class analysis approach

Catalog

Books, media, physical & digital resources

3. TOMATO ROOT GROWTH UNDER DIFFERENT SOIL AND CLIMATE CONDITIONS

4. Association between the development of autoimmune hypothyroidism and objective response to nivolumab: report of two cases

5. Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

7. QUALITOM, A EUROPEAN RESEARCH PROGRAMME TO BUILD AND TEST A TECHNICAL ITINERARY MODEL IN PROCESSING TOMATO CROPPING

8. Prognostic Factors for Survival in Metastatic Renal Cell Carcinoma: Retrospective Analysis from 109 Consecutive Patients

9. Isolated Left Ventricular Filling Abnormalities May Predict Interleukin-2-Induced Cardiovascular Toxicity

10. Significant Association Between VEGF-A and ABCB1 Polymorphisms and Survival in Metastatic Pancreatic Adenocarcinoma (MPA) patients (Pts) treated with Maintenance Sunitinib (MS)

11. Evaluation of the environmental impact of the pesticides applied in processing tomato cropping

12. Review of the influence of major environmental and agronomic factors on the lycopene content of tomato fruit

14. TH-302 + Gemcitabine (G + T) vs Gemcitabine (G) in Patients with Previously Untreated advanced Pancreatic Cancer (PAC)

15. Intensive chemotherapy with recombinant-human granulocyte-macrophage colony stimulating factor (r-hu-gm-csf) for small cell lung cancer (sclc): a pilot study

16. Treatment of advanced renal cell cancer with sequential intravenous recombinant interleukin-2 and subcutaneous alpha-interferon

17. Autoimmune thyroiditis following interleukin-2 and LAK cell therapy for metastatic renal cell carcinoma: correlation with tumor regression

18. 580 Assessment of interleukin-2-induced cardiovascular toxicity by cardiac echocardiography

20. A phase II study of continuous intravenous infusion (CIVI) recombinant IL-2 and subcutaneous α-interferon by sequential administration in advanced renal cell cancer

21. A single-centre experience with continuous intravenous infusion of recombinant interleukin-2 ± lak cells in metastatic renal cell cancer

22. RTO — A Management System for a Computerized Cancer Registry

23. Nitrate and pesticide residues in processing tomato fruits

24. The long-term follow-up of the living liver donors.

25. Predicting the Risk of Morbidity by GLIM-Based Nutritional Assessment and Body Composition Analysis in Oncologic Abdominal Surgery in the Context of Enhanced Recovery Programs : The PHase Angle Value in Abdominal Surgery (PHAVAS) Study.

26. Association of chronic statin use, myopenia, myosteatosis and major morbidity in surgical patients with upper gastrointestinal cancer.

27. Exploring the Association between Delirium and Malnutrition in COVID-19 Survivors: A Geriatric Perspective.

28. Association of indirect measurement of cell function by bioimpedance analysis with complications in oncologic hepatic surgery.

29. Predictors and outcomes of delirium in the emergency department during the first wave of the COVID-19 pandemic in Milan.

30. Disseminated Mycobacterium chimaera infection favoring the development of Kaposi's sarcoma: a case report.

31. Outcomes of noninvasive ventilation as the ceiling of treatment in patients with COVID-19.

32. A novel evidence-based algorithm to predict thromboembolism in patients with COVID-19: preliminary data from a single-center cohort.

33. Frailty as a predictor of mortality in COVID-19 patients receiving CPAP for respiratory insufficiency.

34. Six-month respiratory outcomes and exercise capacity of COVID-19 acute respiratory failure patients treated with continuous positive airway pressure.

35. Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19.

36. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.

37. Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: a phase II randomised trial.

38. Discontinuation of bevacizumab and FOLFIRI administered up to a maximum of 12 cycles as first-line therapy for metastatic colorectal cancer: a retrospective Italian study.

39. Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA).

41. Treatment of advanced renal cell cancer with sequential intravenous recombinant interleukin-2 and subcutaneous alpha-interferon.

43. Autoimmune thyroiditis following interleukin-2 and LAK cell therapy for metastatic renal cell carcinoma: correlation with tumor regression.

44. Cimetidine treatment in hyper-IgM hypogammaglobulinemia.